Skip to content

Medline Level 2 Surgical Gown (Eclipse Non-Reinforced), Medline Level 3 Surgical Gown (Eclipse Fabric Reinforced), Medline Level 3 Surgical Gown (Sirus Non-Reinforced), Medline Level 3 Surgical Gown (Sirus Fabric Reinforced), Medline Level 3 Surgical Gown (Aurora Non Reinforced & Aurora Fabric Reinforced)

by Medline Industries, Inc.

510(k) K190950

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK190950 Date4 Jul 2019ClearedStatusActive

Recalls

2 recalls · 2 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-2129-2026 FDA Class II initiated 7 Jan 2026
    • Ongoing Z-1424-2026 FDA Class II initiated 7 Jan 2026

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
FYA
Device Class
Class II
Regulation
21 CFR Part 878.4040
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a surgical gown, as defined by its device type and nomenclature authority. It is designed to provide barrier protection during surgical procedures, with specific models offering AAMI Level 2 or Level 3 protection based on fabric construction and reinforcement. The gowns are available in non-reinforced and fabric-reinforced variants across multiple product lines including Eclipse, Sirus, and Aurora.

The gowns are supplied as single-use, sterile devices intended for use in healthcare settings such as operating rooms. They are cleared under FDA 510(k) authorization (K190950) with product code FYA and are classified as substantially equivalent. Sizes include XL (47 in) as referenced in the web context, and they are distributed in cases of 30 units. Storage and handling should follow standard practices for sterile single-use medical devices.

Other devices from Medline Industries, Inc.

See all devices from Medline Industries, Inc. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the intended use of these Medline surgical gowns?

    These surgical gowns are designed to provide barrier protection during surgical procedures, with specific models offering AAMI Level 2 or Level 3 protection based on fabric construction and reinforcement, as defined by their device type and nomenclature authority.

  • How are these gowns supplied and are they reusable?

    The gowns are supplied as single-use, sterile devices intended for use in healthcare settings such as operating rooms, and are distributed in cases of 30 units; they are not designed for reuse due to their sterile, single-use nature.

  • What sizes are available for these Medline surgical gowns?

    Sizes include XL (47 in) as referenced in the web context, with the gowns available across multiple product lines including Eclipse, Sirus, and Aurora in both non-reinforced and fabric-reinforced variants.

  • What regulatory pathway was used for these gowns?

    The gowns are cleared under FDA 510(k) authorization (K190950) with product code FYA and are classified as substantially equivalent, as indicated by the decision code SESE and decision description 'Substantially Equivalent'.